Cendakimab (Anti-IL-13)Cendakimab (Anti-IL-13)
Move your mouse over image or click to enlarge

Cendakimab (Anti-IL-13)

Cendakimab (anti-IL-13) is a humanized, recombinant monoclonal antibody against the interleukin-13 (IL-13) molecule with the potential to treat allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis). MW: 146.44 KD.
Cat# Size Price Qty Buy
A2949-1mg*25 1mg*25
£2,432.00
A2949-1mg*5 1mg*5
£794.00
A2949-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2949

Related Documents